Alternatively, IRS-1 and IRS-2 may independently regulate their functional outcomes through the formation of unique scaffolding interactions [30], with the ability of IRS-2 to promote tumor progression being dominant to the suppressive activity of IRS-1. The gene discussed is IRS1; the disease is neoplasm.